BROOK S/A

Brook Biotech is a Biopharmaceutical, sales and distribution company with a relevant portfolio of hospital and highly complex medicines focused on relevant segments in the pharmaceutical industry, such as immunology, hematology, oncology, nephrology, specialties, antibiotics and plasma-derived therapies acting in different therapeutic classes, With quality standards and state-of-the-art technology, focused on serving the market for biological, oncological, antibiotics, anesthetics, blood products, in their injectable, subcutaneous and other forms. Our portfolio consists of private label, generic and similar, biological and synthetic products, with a high production capacity and great growth potential in the Global healthcare market. Brook Biotech is focused on the Institutional segment, which comprises public and private hospitals and clinics, including chemotherapy and hemodialysis centers in all of our operating regions. We work so that our patients have maximum safety in terms of the risk of adverse reactions, quality in storage, logistics and distribution, and a reliable reputation that we always take into account by health institutions, prescribing physicians, nurses and pharmacists We focus our efforts to provide the best treatment for the patient, For this reason, we maintain priority in the use of resources to always bring the best to our markets. We are interested in growing together with the market, always collaborating to improve the population's health and gain quality of life.